SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 8, 2003
NEOSE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| of incorporation) |
|
File Number) |
|
Identification No.) |
| |
| |
| |
| |
Item 5. Other Events.
Announcement of Plans to Develop Proprietary Second Generation Versions of Therapeutic Proteins. On January 8, 2002, Neose Technologies, Inc. (the “Company”) presented its plans to develop proprietary second generation proteins and data on product profile improvements made to its first proprietary product candidate, at the JPMorgan H&Q healthcare conference in San Francisco. The Company’s presentation, which was webcast, included the slides set forth in Exhibit 99.1 to this Report on Form 8-K.
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits.
(a) Financial Statements of Businesses Acquired: None
(b) Pro Forma Financial Information: None
(c) Exhibits: Reference is made to the Exhibit Index annexed hereto and made a part hereof.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| NEOSE TECHNOLOGIES, INC. | ||
| By: | /s/ Debra J. Poul | |
| Debra J. Poul | ||
| Senior Vice President, General Counsel | ||
Dated: January 8, 2003
-3-
EXHIBIT INDEX
| Exhibit No. | | |
| 99.1 | Slides presented by Neose Technologies, Inc. at JP Morgan H&Q Healthcare Conference on Wednesday, January 8, 2003. |
-4-